Clorox Company (The) (NYSE:CLX) – Jefferies Group issued their Q1 2018 earnings estimates for shares of Clorox Company (The) in a report released on Friday. Jefferies Group analyst K. Grundy expects that the company will earn $1.41 per share for the quarter. Jefferies Group currently has a “Hold” rating and a $138.00 target price on the stock. Jefferies Group also issued estimates for Clorox Company (The)’s Q2 2018 earnings at $1.35 EPS, Q3 2018 earnings at $1.26 EPS, Q4 2018 earnings at $1.63 EPS, FY2019 earnings at $6.00 EPS and FY2020 earnings at $6.37 EPS.

A number of other research firms have also recently weighed in on CLX. Vetr cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective on the stock. in a research report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price objective on shares of Clorox Company (The) and gave the company a “hold” rating in a research report on Monday, April 24th. BMO Capital Markets set a $150.00 price objective on shares of Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Barclays PLC cut their price objective on shares of Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating on the stock in a research report on Friday. Finally, BidaskClub cut shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $129.13.

WARNING: “Clorox Company (The) (NYSE:CLX) Expected to Earn Q1 2018 Earnings of $1.41 Per Share” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/08/clorox-company-the-nyseclx-expected-to-earn-q1-2018-earnings-of-1-41-per-share.html.

Shares of Clorox Company (NYSE:CLX) traded down 0.05% during midday trading on Monday, reaching $135.43. 67,316 shares of the company’s stock traded hands. The company has a 50-day moving average of $134.79 and a 200-day moving average of $133.07. The company has a market capitalization of $17.44 billion, a price-to-earnings ratio of 26.75 and a beta of 0.40. Clorox Company has a one year low of $111.24 and a one year high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.30 EPS.

Several hedge funds have recently modified their holdings of CLX. Jacobi Capital Management LLC raised its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after buying an additional 4 shares in the last quarter. Bridgeworth LLC raised its stake in Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after buying an additional 5 shares during the period. Valley National Advisers Inc. raised its stake in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. raised its stake in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Bernzott Capital Advisors raised its stake in Clorox Company (The) by 0.4% in the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after buying an additional 7 shares during the period. 70.29% of the stock is owned by hedge funds and other institutional investors.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Earnings History and Estimates for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.